IZZI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 10.652
AS - Asia 1.884
EU - Europa 1.618
SA - Sud America 308
AF - Africa 55
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.529
Nazione #
US - Stati Uniti d'America 10.571
SG - Singapore 794
IT - Italia 443
CN - Cina 345
BR - Brasile 256
RU - Federazione Russa 248
IE - Irlanda 192
VN - Vietnam 175
DE - Germania 168
HK - Hong Kong 161
GB - Regno Unito 121
KR - Corea 109
BD - Bangladesh 94
UA - Ucraina 84
FR - Francia 83
FI - Finlandia 81
JP - Giappone 70
CA - Canada 52
NL - Olanda 51
IN - India 31
SE - Svezia 28
AR - Argentina 23
AT - Austria 23
ID - Indonesia 20
EG - Egitto 18
CZ - Repubblica Ceca 17
MX - Messico 17
TR - Turchia 17
PL - Polonia 16
ZA - Sudafrica 16
ES - Italia 13
BE - Belgio 10
IQ - Iraq 9
PH - Filippine 9
CL - Cile 8
CH - Svizzera 7
GR - Grecia 6
AU - Australia 5
EC - Ecuador 5
KE - Kenya 5
PE - Perù 5
RO - Romania 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
DZ - Algeria 4
ET - Etiopia 4
MY - Malesia 4
NP - Nepal 4
QA - Qatar 4
SA - Arabia Saudita 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
CO - Colombia 3
EU - Europa 3
HU - Ungheria 3
JM - Giamaica 3
KZ - Kazakistan 3
LT - Lituania 3
PK - Pakistan 3
PY - Paraguay 3
TH - Thailandia 3
AZ - Azerbaigian 2
CR - Costa Rica 2
IL - Israele 2
IR - Iran 2
JO - Giordania 2
LB - Libano 2
LK - Sri Lanka 2
MA - Marocco 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
SI - Slovenia 2
TN - Tunisia 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BW - Botswana 1
GE - Georgia 1
GP - Guadalupe 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
NR - Nauru 1
RS - Serbia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 14.529
Città #
Wilmington 2.560
Houston 2.461
Woodbridge 1.581
Singapore 478
Ashburn 457
Fairfield 407
Chandler 325
San Jose 247
Seattle 195
Beijing 170
Dublin 164
Cambridge 159
Hong Kong 156
Ann Arbor 149
New York 138
Council Bluffs 131
Medford 115
Rome 113
Santa Clara 90
The Dalles 78
Los Angeles 76
Dearborn 72
Helsinki 56
Ho Chi Minh City 55
Lawrence 54
Tokyo 49
Milan 48
Lauterbourg 47
Hanoi 44
Buffalo 42
Menlo Park 40
Monte Vista 40
Munich 40
Moscow 39
Boardman 34
San Diego 34
Jacksonville 33
São Paulo 33
Dallas 28
London 22
Toronto 22
North Bergen 21
Orem 21
Chicago 18
Amsterdam 17
Columbus 17
Brno 16
Seoul 16
Brooklyn 14
Stockholm 14
Atlanta 13
Miano 13
Norwalk 13
Redwood City 13
Istanbul 12
Jakarta 12
Cairo 11
Frankfurt am Main 11
Johannesburg 11
Vienna 11
Warsaw 11
Belo Horizonte 10
Brussels 10
Da Nang 10
Manchester 10
Montreal 10
Phoenix 10
Salt Lake City 10
Chennai 9
Denver 9
Kilburn 9
Nuremberg 9
Zhengzhou 9
Bologna 8
Boston 8
Haiphong 8
Lappeenranta 8
Mexico City 8
San Francisco 8
Santiago 8
Tōyō 8
Guangzhou 7
Mumbai 7
Nanjing 7
Naples 7
Palo Alto 7
Philadelphia 7
Tsu 7
Athens 6
Poplar 6
Porto Alegre 6
Redondo Beach 6
Washington 6
City of London 5
Kunming 5
Nairobi 5
Palermo 5
Rio de Janeiro 5
Bari 4
Biên Hòa 4
Totale 11.658
Nome #
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 506
Predicting seizures in untreated temporal lobe epilepsy using point-process nonlinear models of heartbeat dynamics 484
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments 479
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 458
Optic Nerve dysfunction in obstructive sleep apnea: An electrophysiological study 448
Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases 429
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 428
Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time 426
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population 423
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? 387
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 380
Folic acid supplements during pregnancy in specific clinical settings: What dowe know about epilepsy? 374
Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study 368
MicroRNA expression is dysregulated in narcolepsy: A new evidence? 366
Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: Further data 366
Obstructive sleep apnoea and bone health 355
Continuous positive airway pressure treatment may improve optic nerve function in obstructive sleep apnea: An electrophysiological study 319
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology 315
Postural and vestibular changes related to CPAP treatment in moderate-to-severe OSA patients: a 12-month longitudinal study 290
Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study 285
Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk? 278
Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms 266
Feasibility of automated detection of sleep apnea using implantable pacemakers and defibrillators: a comparison with simultaneous polysomnography recording 263
Heart rate variability in untreated newly diagnosed temporal lobe epilepsy: Evidence for ictal sympathetic dysregulation 258
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 258
CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study 250
Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine 246
Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 244
Lower instantaneous entropy of heartbeat dynamics during seizures in untreated temporal lobe epilepsy 233
Seasonality of restless legs syndrome: symptom variability in winter and summer times 221
Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies 200
Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid 198
Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation 189
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease 187
Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis 186
18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment 176
Obstructive sleep apnea is associated with early but possibly modifiable Alzheimer's disease biomarkers changes 175
Pitolisant for treating narcolepsy comorbid with Parkinson's disease 167
Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1 159
The actigraphic documentation of circadian sleep-wake rhythm dysregulation in myotonic dystrophy type 1 151
Heart rate variability parameters during psychogenic non-epileptic seizures: comparison between patients with pure PNES and comorbid epilepsy 141
New revolution in the assessment of cerebrospinal fluid orexin-A: Enzyme-linked immunosorbent assay! 138
Cerebrospinal-fluid biomarkers for predicting phenoconversion in patients with isolated rapid-eye movement sleep behavior disorder 130
Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy 128
Autonomic symptoms, cardiovascular and sudomotor evaluation in de novo type 1 narcolepsy 121
Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy? 111
Obstructive sleep apnea syndrome and Alzheimer's disease pathology: may continuous positive airway pressure treatment delay cognitive deterioration? 108
Sleep-wake cycle dysregulation in idiopathic REM sleep behaviour disorder 98
Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease. 97
Correction to: Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 93
Nocturnal hypoxia and sleep fragmentation may drive neurodegenerative processes: the compared effects of obstructive sleep apnea syndrome and periodic limb movement disorder on Alzheimer's disease biomarkers 92
Neuroimaging findings in leukoencephalopathy with calcifications and cysts: case report and review of the literature 89
Brivaracetam as early add-on treatment in patients with focal seizures: a retrospective, multicenter, real-world study 86
Clinical characteristics of a large cohort of patients with narcolepsy candidate for pitolisant: a cross-sectional study from the Italian PASS Wakix® Cohort 85
Derivation and Validation of a Phenoconversion-Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder 85
Effectiveness of Highly Purified Cannabidiol in Refractory and Super-Refractory Status Epilepticus: A Case Series 81
Periodic sharp wave complexes identify a distinctive phenotype in Creutzfeldt-Jacob disease. 81
Perampanel may represent an effective treatment for the prevention of migraine comorbid with epilepsy 79
Insular monoaminergic deficits in prodromal α-synucleinopathies 77
Brainstem impairment in obstructive sleep apnoea and the effect of CPAP treatment: an electrophysiological blink reflex study 71
A preliminary study investigating the clinical potential of measuring cerebrospinal-fluid lactate levels in patients with narcolepsy type 1 and 2 70
Depressive symptoms in patients with epilepsy and clinically associated features in a single tertiary center 66
Continuous positive airway pressure treatment improves bone mineral density in men affected by severe obstructive sleep apnea syndrome 59
More than sleep and wake disturbances: An actigraphic study showing the sleep-wake pattern dysregulation in epilepsy 59
Sleep Dysregulation Is Associated with 18F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease 56
Neuropsychiatric, neuropsychological, and neuroimaging features in isolated REM sleep behavior disorder: The importance of MCI 56
Generalized Fast Discharges Along the Genetic Generalized Epilepsy Spectrum: Clinical and Prognostic Significance 49
OBSTRUCTIVE SLEEP APNEA AS A RISK FACTOR FOR OSTEOPENIA AND OSTEOPOROSIS IN THE MALE POPULATION 42
Blood-brain barrier impairment as an early marker of neurodegeneration in late-onset epilepsy of unknown origin 15
Cenobamate modulates EEG cortical activity and connectivity in individuals with drug-resistant epilepsy: a pharmaco-EEG study 14
Gut microbiome composition changes in obstructive sleep apnoea syndrome also in relation to excessive daytime sleepiness 13
The potential role of interleukin-6 in the association between inflammation and cognitive performance in obstructive sleep apnea 12
Increased neutrophil-to-lymphocyte ratio as a possible marker to detect neuroinflammation in patients with narcolepsy type 1 12
Sleep architecture in drug-naïve adult patients with epilepsy: Comparison between focal and generalized epilepsy 11
The effect of lacosamide monotherapy on sleep architecture in patients with epilepsy: a preliminary evidence 11
Perampanel effects on cognition and quantitative EEG in patients with epilepsy 10
Alexithymia, impulsiveness, emotion, and eating dyscontrol: similarities and differences between narcolepsy type 1 and type 2 10
CSF dynamics of orexin and β-amyloid42 levels in narcolepsy and Alzheimer’s disease patients: a controlled study 10
Perampanel Increases Cortical EEG Fast Activity in Child and Adult Patients Affected by Epilepsy: A Quantitative EEG Study 9
Variability of excessive daytime sleepiness and cataplexy according to seasonality: A study in central disorders of hypersomnolence 9
The Sleepiness–Depression Link in Obstructive Sleep Apnea: Preliminary Results on the Mediation of Impulsivity 9
Sex effect on time to diagnosis and clinical features of narcolepsy type 1 and 2 9
Integrating postural and vestibular dimensions to depict impairment in moderate-to-severe obstructive sleep apnea syndrome patients 8
Cognitive functioning, cerebrospinal fluid Alzheimer's disease biomarkers and cerebral glucose metabolism in late‐onset epilepsy of unknown aetiology: A prospective study 8
Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study 8
null 7
Vitamin D status of male OSAS patients improved after long-term CPAP treatment mainly in obese subjects 7
Persistent blood-brain barrier dysregulation in patients with obstructive sleep apnea following long-term continuous positive airway pressure treatment 7
Oral l-carnitine as treatment for narcolepsy without cataplexy during pregnancy: A case report 7
Refractory restless legs syndrome remitting after dual kidney transplantation 7
Commentary: Sleep changes without medial temporal lobe or brain cortical changes in community-dwelling individuals with subjective cognitive decline 7
Letter re: Prolonged sleep duration as a marker of early neurodegeneration predicting incident dementia 7
Totale 14.866
Categoria #
all - tutte 47.264
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.264


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 0 23
2021/2022661 27 46 26 11 16 18 65 15 33 53 40 311
2022/2023846 103 77 39 104 69 174 65 53 84 16 37 25
2023/2024443 43 10 24 23 36 146 21 37 8 27 6 62
2024/20251.391 62 286 148 97 36 121 67 67 142 122 140 103
2025/20263.269 251 80 332 301 243 124 398 323 328 291 471 127
Totale 14.866